Home›People›Lauren Otsuki
LO

Lauren Otsuki

President and Chief Executive Officer, director at SRT Therapeutics. Also a director at Evida Biosciences and an executive officer and director at GLO Pharma.

ExecutiveDirectorRoles at 3 startups
Updated Nov 9, 2026·Latest SEC filing Aug 14, 2025·Suggest an edit

About Lauren Otsuki

Lauren Otsuki is a president and chief executive officer, director at SRT Therapeutics.

Form D filings also name Lauren Otsuki as a director at Evida Biosciences and an executive officer and director at GLO Pharma.

Lauren Otsuki first appears on SEC filings in 2020.

Experience

This experience comes from SEC filings. The years are when the filings name Lauren Otsuki in the role, so the role may have started earlier or lasted longer.

SRT Therapeutics, Inc.
President and Chief Executive Officer, director
2025 · San Diego, CA
Evida Biosciences Inc.
Director
2024 · San Diego, CA
GLO Pharma, Inc.
Executive officer and director
2020 – 2023 · Carlsbad, CA

Key Colleagues at Startups

The people Lauren Otsuki works with at each company, as listed on that company's latest Form D.

SRT Therapeutics, Inc. · Form D, Aug 14, 2025
RB
EP
MW
Evida Biosciences Inc. · Form D, Oct 11, 2024
SG
Scott Glenn
Director
MW
Michael Walsh
President, Secretary and Chief Financial Officer, director
RB
DW
GLO Pharma, Inc. · Form D/A, Sep 11, 2023
DQ
NQ
Nicole Quinn
Director
MB
Marla Beck
Director
MC
Maureen Case
Director
FS
DW
Douglas Wall
Director
VG
Vimla Black-Gupta
President and Chief Executive Officer, director

Sources

  1. SECSRT Therapeutics, Inc. Form D, filed Aug 14, 2025
  2. SECEvida Biosciences Inc. Form D, filed Oct 11, 2024
  3. SECGLO Pharma, Inc. Form D/A, filed Sep 11, 2023